THL Equity Fund VII Investors (inVentiv), L.P.
CIK 1713160 · last filed 2021-05-14
THL Equity Fund VII Investors (inVentiv), L.P. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for SYNH, was dated May 14, 2021. Current disclosed insider exposure totals $22.9M across reported positions. The firm reports its address in Boston, MA. 14 SEC filings were submitted jointly with THL Executive Fund VII, L.P.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SYNH price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
100 FEDERAL STREET, 35TH FLOOR
BOSTON, MA 02110
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Syneos Health, Inc. (SYNH) Delisted | Director | 5,601,782 | $42.98 | $240.76M | $0 | 2 | 2021-05-14 |
| INCR | 10%+ Owner | 5,048,369 | $4.53 | $22.87M | $0 | 1 | 2017-08-03 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-14 | Syneos Health, Inc. (SYNH) Delisted | Grant (A) | +28,368 | $0 | EDGAR |
| 2018-05-29 | Syneos Health, Inc. (SYNH) Delisted | Grant (A) | +65,648 | $0 | EDGAR |
| 2017-08-03 | INCR | Grant (A) | +34,848 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.